CRISTINA REFAHIYAT: Open Payments
NPI 1609374651 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 29 payments from 7 companies in 2025. Trend: 2023 $445 · 2024 $730 · 2025 $646
Food & beverage: $574Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $239 |
| Novartis Pharmaceuticals Corporation | 15 | $208 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $94 |
| UCB, Inc. | 1 | $40 |
| Almirall LLC | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $15 |
Products named: TREMFYA, COSENTYX, SPEVIGO, Bimzelx, Seysara, DUPIXENT, SKYRIZI.
Industry payments across UT — which companies pay providers there.
